Zepatier (elbasvir/grazoprevir)

pCPA File Number: 20910

Negotiation Status:

Concluded with an LOI

Indication(s):

Chronic Hepatitis C

Sponsor/Manufacturer:

Merck Canada Inc.

CDA-AMC Project Number:

SR0454-000

pCPA Engagement Letter Issued:

2016-04-14

Negotiation Process Concluded:

2017-02-17